Cantor Fitzgerald Downgrades Flex Pharma (FLKS) to Hold

October 14, 2016 8:44 AM EDT
Get Alerts FLKS Hot Sheet
Price: $6.20 -0.16%

Rating Summary:
    5 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade FLKS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Cantor Fitzgerald downgraded Flex Pharma (NASDAQ: FLKS) from Buy to Hold with a price target of $10.00 (from $22.00).

For an analyst ratings summary and ratings history on Flex Pharma click here. For more ratings news on Flex Pharma click here.

Shares of Flex Pharma closed at $8.43 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst PT Change, Downgrades

Related Entities

Cantor Fitzgerald

Add Your Comment